Uncategorized

‘Mailman’ gene-editing tool carries molecule to exact ‘zip code’

HQ Team May 24, 2025: Stanford University researchers have developed a gene-editing technology, which they hope will lead to treatments for neurological diseases.

Read More
Health Research

Parkinson’s Disease cases to hit 25 million worldwide by 2050

HQ Team March 10, 2025: A recent study published in The BMJ forecasts a significant rise in Parkinson’s disease cases globally, with projections.

Read More
Health Medical Research

SMC proteins can reverse direction; study redefines DNA dynamics

HQ Team January 26, 2025: Scientists from Delft University of Technology, Vienna Biocenter, and Lausanne have discovered that Structural Maintenance of Chromosomes (SMC).

Read More
Drugs Health Pharma

IntraBio Inc.’s drug for neurogenerative disorder gets US regulator’s nod

IntraBio Inc, a biotechnology company focused on rare and neurogenerative diseases, got the US regulator’s nod for a drug to treat a certain.

Read More
Drugs Health Pharma

European regulator backs Biogen’s drug for amyotrophic lateral sclerosis

HQ Team February 24, 2024: Biogen Inc., a US biotechnology company, has got marketing authorisation from the European medicines regulator for its drug.

Read More
Drugs Health Pharma

Swedish researchers identify new biomarker to detect Parkinson’s disease

HQ Team September 26, 2023: Researchers at Sweden’s Lund University have identified a new biomarker to detect Parkinson’s disease before a person develops.

Read More